DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Howard Jr JF , Utsugisawa K, Benatar M. et al.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Lancet Neurol 2017;
16: 976-986
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.